2026 SCAI SHOCK

Lunch Program: Optimizing Antiplatelet Therapy in Cardiogenic Shock

Accreditation Statement and Credit Designation

The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.​

SCAI designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.​

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.​

Acknowledgment of Commercial Support

This activity is supported by unrestricted education grant(s) from Chiesi.

Introductory Remarks
Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC
DAPT-SHOCK-AMI Trial: Defining the Role of Cangrelor in Patients with AMI and Cardiogenic Shock
Ajar Kochar, M.D., FSCAI, Mass General Brigham: Brigham and Women's Hospital, Chestnut Hill, MA
Unanswered Questions in the Use of Cangrelor for Cardiogenic Shock
Perwaiz M. Meraj, M.D., FSCAI, Northwell Health North Shore University Hospital, Manhasset, NY